Why choose us?
Novel Drug Variants
Unique Peptide Structure Synthesis Capability
Novel peptides and new structural design techniques of FDA-approved therapeutics including conjugation, scaffolding and cyclisation
Optimal Synthesis
Reduced Waste and Higher Yield
Synthesizes linear GLP-1 drugs with typically 50% less waste and cost, and significantly higher purities
Enhanced Purification
Less Cost & Faster Process
Purifies peptide drugs with typically 50% less cost and 100% faster
Low Change Adoption
No Capital Investment Required
Both of our technologies require no new capital investment, at both laboratory and process scales of use
Constantly improving
We are always improving our current technologies and expanding our portafolio.
Drug Development using
our New Synthesis Approach
New proprietary method for industrial peptide synthesis allows the development of new peptide structures for known targets, new drug classes, and the greener synthesis of current therapeutic peptides:
We can develop unique structural forms of peptide therapeutics with known targets
This technology drives the discovery of new drugs
Easy synthesis of cyclic peptides for oral delivery
Synthesis entirely in the solid phase
New proprietary approach for peptide purification using the industry standard method of Reverse Phase Liquid Chromatography which can:
SMART Industrial Peptide Purification
SMART Industrial Peptide Purification
New proprietary approach for peptide purification using the industry standard method of Reversed-Phase Liquid Chromatography
Decrease overall peptide impurity levels
Increase purity of primary peptide species by ~20% whilst reducing unit processing time and usage of solvents/reagents by 2-fold
100% improvement in purification process utilisation